Cargando…
Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407029/ http://dx.doi.org/10.1186/2045-7022-5-S2-P1 |